Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-74, 2010. ,
DOI : 10.1182/blood-2009-07-235358
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study, Journal of Hematology & Oncology, vol.6, issue.1, p.15, 2013. ,
DOI : 10.1182/blood-2002-08-2398
Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis, Biology of Blood and Marrow Transplantation, vol.20, issue.6, pp.816-838, 2014. ,
DOI : 10.1016/j.bbmt.2014.02.020
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT, Leukemia, vol.100, issue.4, pp.779-86, 2014. ,
DOI : 10.1182/blood.V98.8.2332
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, Bone Marrow Transplantation, vol.8, issue.4, pp.476-82, 2015. ,
DOI : 10.1016/j.bbmt.2014.05.015
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia, vol.90, issue.9, pp.1891-900, 2015. ,
DOI : 10.1182/blood-2008-02-140095
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets, Journal of Hematology & Oncology, vol.8, issue.1, p.84, 2015. ,
DOI : 10.1016/j.bbmt.2005.09.004
Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors, Journal of Clinical Oncology, vol.31, issue.19, pp.2437-2486, 2013. ,
DOI : 10.1200/JCO.2012.46.6193
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants, Blood, vol.103, issue.1, pp.347-52, 2004. ,
DOI : 10.1182/blood-2003-07-2603
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT, Blood, vol.122, issue.19, pp.3359-64, 2013. ,
DOI : 10.1182/blood-2013-05-499830
Y-antigen killing by T cells of women is restricted by HLA, Nature, vol.4, issue.5602, pp.544-549, 1977. ,
DOI : 10.1038/262795a0
Molecules and mechanisms of the graft-versus-leukaemia effect, Nature Reviews Cancer, vol.4, issue.5, pp.371-80, 2004. ,
DOI : 10.1038/nrc1365
Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation, The Journal of Experimental Medicine, vol.96, issue.8, pp.1133-1175, 2004. ,
DOI : 10.1191/096120398678920613
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission, Blood, vol.105, issue.7, pp.2973-2981, 2005. ,
DOI : 10.1182/blood-2004-09-3660
Clinical impact of H-Y alloimmunity, Immunologic Research, vol.107, issue.20, pp.249-58, 2014. ,
DOI : 10.1007/s12026-014-8514-3
Advances in graft-versus-host disease biology and therapy, Nature Reviews Immunology, vol.69, issue.6, pp.443-58, 2012. ,
DOI : 10.1038/nri3212
Current issues in chronic graft-versus-host disease, Blood, vol.124, issue.3, pp.374-84, 2014. ,
DOI : 10.1182/blood-2014-01-514752
The biology of graft-versus-host disease: experimental systems instructing clinical practice, Blood, vol.124, issue.3, pp.354-62, 2014. ,
DOI : 10.1182/blood-2014-02-514745
High Number of Memory T Cells Is Associated with Higher Risk of Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.21, issue.3, pp.569-74, 2014. ,
DOI : 10.1016/j.bbmt.2014.12.009
CD4 T Cells with Effector Memory Phenotype and Function Develop in the Sterile Environment of the Fetus, Science Translational Medicine, vol.6, issue.238, pp.238-272, 2014. ,
DOI : 10.1126/scitranslmed.3008748
URL : https://hal.archives-ouvertes.fr/hal-01060153
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy, Blood, vol.123, issue.1, pp.133-173, 2014. ,
DOI : 10.1182/blood-2013-05-506253
Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality, Transfusion, vol.52, pp.340-52, 2014. ,
DOI : 10.1111/trf.12257
HA-1 AND THE SMCY-DERIVED PEPTIDE FIDSYICQV (H-Y) ARE IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGENS AFTER BONE MARROW TRANSPLANTATION1, Transplantation, vol.66, issue.7, pp.910-916, 1998. ,
DOI : 10.1097/00007890-199810150-00016
Antileukemic Effect of Chronic Graft-versus-Host Disease, New England Journal of Medicine, vol.304, issue.25, pp.1529-1562, 1981. ,
DOI : 10.1056/NEJM198106183042507
Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning, Journal of Clinical Oncology, vol.23, issue.9, pp.1993-2003, 2005. ,
DOI : 10.1200/JCO.2005.08.136
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation, Leukemia, vol.11, issue.12, pp.2462-2470, 2012. ,
DOI : 10.1056/NEJMoa1108188
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation, Journal of Clinical Oncology, vol.31, issue.12, pp.1530-1538, 2013. ,
DOI : 10.1200/JCO.2012.45.0247
Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance, Critical Reviews in Oncology/Hematology, vol.79, issue.2, pp.112-138, 2011. ,
DOI : 10.1016/j.critrevonc.2010.07.009
Umbilical cord blood transplantation: the first 25 years and beyond, Blood, vol.122, issue.4, pp.491-499, 2013. ,
DOI : 10.1182/blood-2013-02-453175
Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies, Bone Marrow Transplantation, vol.75, issue.5, pp.634-643, 2014. ,
DOI : 10.1182/blood-2004-09-3660
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2??Gy TBI or ATG plus 8??Gy TLI: a phase II randomized study from the Belgian Hematological Society, Journal of Hematology & Oncology, vol.8, issue.1, p.4, 2015. ,
DOI : 10.1016/j.bbmt.2005.09.004
Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG), Journal of Hematology & Oncology, vol.18, issue.11, p.59, 2014. ,
DOI : 10.1186/s13045-014-0059-3
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis, Leukemia, vol.18, issue.11, pp.2235-2275, 2014. ,
DOI : 10.1002/ajh.23404
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia, Blood, vol.73, pp.1720-1728, 1989. ,
Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies, Bone Marrow Transplantation, vol.96, issue.1, pp.45-50, 2015. ,
DOI : 10.1016/S1083-8791(03)00127-7
Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning, Clinical Cancer Research, vol.21, issue.14, pp.3131-3140, 2015. ,
DOI : 10.1158/1078-0432.CCR-14-3374
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius, Blood, vol.117, issue.23, pp.6375-82, 2011. ,
DOI : 10.1182/blood-2011-01-329821
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation, Bone Marrow Transplantation, vol.47, issue.3, pp.389-96, 2014. ,
DOI : 10.1038/bmt.2012.131
Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopoietic Stem Cell Transplantation with or without anti-lymphocyte globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATG family study), Blood, vol.124, p.37, 2014. ,
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplantation, vol.90, issue.7, pp.887-94, 2014. ,
DOI : 10.1182/blood-2012-06-379040
Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission, Bone Marrow Transplantation, vol.115, issue.7, 2015. ,
DOI : 10.1038/bmt.2015.59
CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S, Transplantation, vol.18, issue.4, pp.295-304, 1974. ,
DOI : 10.1097/00007890-197410000-00001